Induced Pluripotent Stem Cells Market to Reach $5.2 Billion by 2028 with a 9.1% CAGR Growth ...

Scientists have engineered a hybrid mouse with a gene that predates all animal life. The team replaced a single gene in the ...

Scientists in Boston, Massachusetts have made reprogrammed stem cells from the blood of centenarians. They plan to share the ...

Induced pluripotent stem-cell-derived corneal epithelium to treat limbal stem cell deficiency could transform eye care and ...

Stem cell therapies provide hope for patients with heart disease, blindness, Parkinson's, HIV, diabetes and spinal cord ...

SAN DIEGO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to ...

Using a gene-screening method they created, Stanford Medicine researchers may have discovered why an effective chemotherapy ...

Using a gene-screening method, Stanford Medicine researchers have uncovered why chemotherapy can damage heart cells and have ...

This research investigates the molecular mechanisms by which SMAD2/3-SMYD2 and developmental transcription factors cooperate ...

A live webcast of the fireside chat can be accessed on the “Events & Presentations” page in the “Investors” section of the Company’s website at https://investors.centurytx.com/events-and-presentations ...

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, United States ...